Marta Guix

3PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 08, 2022
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study.

Joana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall

|May 23, 2022
p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis.

Laura Solé, Teresa Lobo-Jarne, Daniel Álvarez-Villanueva

Pageof 1